Your session is about to expire
← Back to Search
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Partial hand amputees with absence of index and/or middle fingers and presence of thumb. Additional finger loss is acceptable if all other criterion are met.
Fluent in English
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day 1 (10 minutes)
Awards & highlights
Study Summary
This trial will test whether the Point Digit system can help people with partial hand amputations complete everyday tasks.
Eligible Conditions
- Hand Amputation
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ day 1 (10 minutes)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day 1 (10 minutes)
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
VAL-1: System Comfort Validation Test
VAL-2: Unilateral Function Validation Test
VAL-3.1: System Robustness Validation Test with 25 lb Bag
+7 moreTrial Design
1Treatment groups
Experimental Treatment
Group I: ProsthesisExperimental Treatment1 Intervention
Patient is temporarily fit with Point Digit partial hand prosthetic system
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Point Digit
2020
N/A
~20
Find a Location
Who is running the clinical trial?
University of Colorado, DenverOTHER
1,726 Previous Clinical Trials
2,141,669 Total Patients Enrolled
Point DesignsLead Sponsor
4 Previous Clinical Trials
40 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger